Pharmaceutical Filtration Market Growth Drivers and Challenges:
Growth Drivers
- Increasing Investment in Biopharmaceutical Research and Development - A very small patient group of people can receive approved medications. Biopharmaceutical companies work hard to produce high-quality pharmaceuticals that patients get for a long time. According to the International Federation of Pharmaceutical Manufacturers & Associations, it is estimated that USD 179 billion was spent globally on the biopharmaceutical industry R & D in 2018. The aggregate contribution from the combined, direct, indirect, and induced effects of the biopharmaceutical industry was USD 1,838 billion to the world’s GDP.
- Upsurge in the Use of Active Pharmaceutical Ingredients (API) – Globally, China produces approximately 75 to 85% of antibiotic APIs whilst Indian companies are leading in the production of finished products.
- Rise in the Utilization of Single-Use Technologies & Systems in the Biopharmaceutical Industry – It was found that single-use bioreactors grew by approximately 59% points over the past 13 years.
- Surge in the Profitability of Large Pharmaceutical Companies - it was observed that, from 2000 to 2018, the cumulative revenue of 35 large pharmaceutical companies was approximately USD 11.5 trillion, with gross profit of more than USD 8.5 trillion, earnings before interest, taxes, depreciation, and amortization (EBITDA) of USD 3.5 trillion, and net income of USD 2 trillion.
- Upsurge in Nanofiltration Membrane Market - in the year 2020, the U.S. nanofiltration market was estimated to be USD19 Million.
Challenges
- Upsurge of Fiber Breakage in Membrane Filters - Pharmaceutical manufacturing facilities frequently fail to filter out all of the chemicals employed in the process, which causes the chemicals to leak into nearby freshwater systems before finally reaching the sea, lakes, streams, and rivers. In China, the polymeric membrane was already widely used to purify drinking water, with just a maximum treatment capacity of 3.8 million tonnes.
- Negative Impact of Active Pharmaceutical Ingredients (API) on Human Health and the Ecosystem
- High Cost Involved in the Installation and Upgradation of the Filtration System
Pharmaceutical Filtration Market Size and Forecast:
|
Base Year |
2024 |
|
Forecast Year |
2025-2034 |
|
CAGR |
8.7% |
|
Base Year Market Size (2024) |
USD 13.82 billion |
|
Forecast Year Market Size (2034) |
USD 31.83 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of pharmaceutical filtration is estimated at USD 14.84 billion.
Pharmaceutical Filtration Market size was over USD 13.82 billion in 2024 and is poised to exceed USD 31.83 billion by 2034, growing at over 8.7% CAGR during the forecast period i.e., between 2025-2034.
North America is poised to account for largest industry share by 2034.
The key market players include 3M, Amazon Filters Ltd., Parker-Hannifin Corporation, Sartorius, Eaton Corporation plc, Graver Technologies LLC, Meissner Filtration Products, Inc., Cole-Parmer Instrument Company, LLC., Donaldson Company, Inc., Danaher Corporation.
